![]() |
市場調查報告書
商品編碼
1389738
體外心律調節器市場 - 按技術(單腔、雙腔)、按應用(心搏過緩、急性心肌梗塞)、最終用途(醫院、心臟護理中心)和預測,2023 - 2032External Pacemaker Market - By Technology (Single-chamber, Dual-chamber), By Application (Bradycardia, Acute Myocardial Infarction), End-use (Hospitals, Cardiac care centers) & Forecast, 2023 - 2032 |
由於心血管疾病發生率的增加以及對增強型治療設備的需求,全球體外起搏器市場在 2023 年至 2032 年間的CAGR將達到 5%。心臟疾病的加劇推動了對外部起搏器的需求,這對於控制心律異常至關重要。
例如,根據世界心臟聯合會(World Heart Federation.org) 發布的《2023 年世界心臟報告》,全球有超過5 億人與心血管疾病作鬥爭,導致2021 年約2,050 萬人死亡,佔全球死亡人數的近三分之一,並且顯著上升。估計有 1.21 億人因 CVD 相關死亡。大約五分之四的心血管疾病死亡發生在低收入和中等收入國家,而心血管健康的進步主要有利於高收入國家。這種明顯的健康差距需要緊急關注和糾正。
隨著人口老化和生活方式因素導致心臟病,迫切需要先進的攜帶式起搏器。體外心律調節器市場需求的激增反映了該行業對開發提供有效心臟管理的創新設備的關注,並努力改善患者的治療結果和生活品質。
整個外部起搏器市場根據應用、最終用戶和地區進行分類。
心搏過緩細分市場將在 2023 年至 2032 年間經歷重大發展。心搏過緩是一種以心率異常緩慢為特徵的疾病,提示需要外部起搏器來調節心律。由於這種情況影響不同年齡的人,市場對攜帶式、有效起搏器的需求激增。心搏過緩發病率的上升凸顯了這些設備在管理心臟異常方面發揮的重要作用,透過創新、高效的體外起搏解決方案推動體外起搏器市場的成長。
從 2023 年到 2032 年,心臟護理中心領域的外部起搏器市場佔有率將實現顯著的CAGR。這些致力於心臟健康的中心依靠外部起搏器及時干預心律不齊。這些設施專注於患者護理和有效治療,推動了市場對可靠、可攜式起搏器的需求。心臟護理中心對這些設備的日益依賴凸顯了它們在管理心臟疾病、推動外部起搏器市場佔有率的進步和創新方面的關鍵作用。
歐洲體外心律調節器產業從 2023 年到 2032 年將呈現出值得稱讚的CAGR。憑藉強調心血管護理的強大醫療保健系統,該地區推動了對先進體外起搏解決方案的需求。由於心血管疾病持續存在,歐洲醫療中心優先考慮可靠的攜帶式起搏器。市場對創新的關注與歐洲最佳化心臟護理的承諾一致,反映了歐洲大陸在引導進步和採用尖端外部起搏技術方面的作用。
Global External Pacemaker Market will witness 5% CAGR between 2023 and 2032 due to increased occurrences of cardiovascular diseases and the quest for enhanced treatment devices. Rising heart conditions drive the demand for external pacemakers, crucial in managing cardiac rhythm abnormalities.
For instance, as per the 2023 World Heart Report by the World Heart Federation.org, over 500 million individuals globally grapple with cardiovascular diseases, resulting in approximately 20.5 million deaths in 2021-nearly one-third of all global fatalities and a notable rise from the estimated 121 million CVD-related deaths. Around 4 out of 5 deaths from CVD occur in low- and middle-income nations, while advancements in cardiovascular health predominantly favor high-income countries. This marked health disparity necessitates urgent attention and rectification.
With a growing aging population and lifestyle factors contributing to heart ailments, there's a pressing need for advanced, portable pacemakers. This surge in the external pacemaker market demand reflects the industry's focus on developing innovative devices that offer effective cardiac management, striving to improve patient outcomes and quality of life.
The overall External Pacemaker Market is classified based on application, end-user, and region.
Bradycardia segment will undergo significant development from 2023 to 2032. Bradycardia, a condition marked by an abnormally slow heart rate, prompts the need for external pacemakers to regulate heart rhythm. As this condition affects individuals of varying ages, the market sees a surge in demand for portable, effective pacemakers. The rising incidence of bradycardia underscores the vital role these devices play in managing cardiac abnormalities, driving the external pacemaker market growth from innovative, efficient external pacing solutions.
The external pacemaker market share from the cardiac care centers segment will register a noteworthy CAGR from 2023 to 2032. These centers, dedicated to heart health, rely on external pacemakers for timely intervention in cardiac rhythm irregularities. With a focus on patient care and effective treatment, these facilities drive the market's need for reliable, portable pacemakers. The increasing reliance on these devices within cardiac care centers underscores their critical role in managing cardiac conditions, propelling advancements and innovation within the external pacemaker market share.
Europe external pacemaker industry will showcase a commendable CAGR from 2023 to 2032. With a robust healthcare system emphasizing cardiovascular care, the region drives the need for advanced external pacing solutions. As cardiovascular conditions persist, European healthcare centers prioritize reliable, portable pacemakers. The market's focus on innovation aligns with Europe's commitment to optimizing cardiac care, reflecting the continent's role in steering advancements and adoption of cutting-edge external pacing technologies.